Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $64.66 USD
Change Today +0.93 / 1.46%
Volume 4.4M
BMY On Other Exchanges
New York
Sao Paulo
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lamberto Andreotti

Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee, Bristol-Myers Squibb Company
AgeTotal Calculated CompensationThis person is connected to 39 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Lamberto Andreotti has been the Chief Executive Officer of Bristol-Myers Squibb Australia Pty Ltd., since March 2, 2010 and Bristol-Myers Squibb Company since May 4, 2010. Mr. Andreotti serves as a Member of Management Council of Bristol-Myers Squibb, where he is responsible for ConvaTec and Mead Johnson Nutritionals. He served as the President of Bristol-Myers Squibb Company from March 3, 2009 to May 2010 and Chief Operating Officer from 2008 to May 2010. He served ...

Read Full Background

Corporate Headquarters*

345 Park Avenue
New York, New York 10154

United States

Phone: 212-546-4000
Fax: --

Board Members Memberships*

Former Director
Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Director, Member of Audit Committee and Member of Science & Technology Committee
Director, Member of Audit Committee and Member of Science & Technology Committee


Massachusetts Institute of Technology
Sapienza University of Rome

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,700,000

Stock Options*

Restricted Stock Awards$18,032,703
All Other Compensation$769,988
Exercised Options108,000
Exercised Options Value$2,651,227
Exercisable Options1,436,835
Exercisable Options Value$52,348,641
Total Value of Options$54,999,867
Total Number of Options1,544,835

Total Compensation*

Total Annual Cash Compensation$8,084,068
Total Short Term Compensation$1,700,000
Other Long Term Compensation$18,802,691
Total Calculated Compensation$27,062,382
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMY:US $64.66 USD +0.93


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at